Biotronik Starts First ICD Study Designed To Measure Sex-Specific Outcomes
Executive Summary
BIO-LIBRA will study Biotronik ICDs and CRT-D devices in about 1,000 patients with non-ischemic cardiomyopathy. The investigators expect at least 40% of the subjects in BIO-LIBRA to be women.
You may also be interested in...
Women Benefit More From CRT-D, Likely Undertreated, CDRH Finds
Women with heart failure, a left bundle block branch and heart-rhythm activity that typically does not qualify them for a top-level guideline recommendation to receive cardiac resynchronization therapy plus defibrillator clearly benefit from the therapy, while men do not, suggesting underuse, according to a study conducted by FDA device center researchers.
Congress Leans On FDA, NIH To Put More Women In Clinical Trials
There was a significant focus on putting more women in clinical trials on Capitol Hill on April 30, when 14 female Senators sent a letter to FDA, calling for an action plan to spur greater subgroup, especially female, participation in clinical trials, while a group of 10 Democrats asked GAO to examine what NIH is doing to meet the same goals.
Clinical Trial Guidance Seeks To Improve Sex-Based Data
Top goal of recent draft guidance is to increase the proportion of women participating in device trials. The document also emphasizes the types of analyses FDA will expect from device manufacturers to make the most of sex-specific data.